Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial Patients – The Wall Street Journal

Share this Story

The Centers for Medicare and Medicaid Services said it will cover the cost of the drug Aduhelm, but as part of further clinical testing

Author: Joseph Walker

READ MORE